scholarly journals Su1888 INTESTINAL ULTRASOUND THROUGHOUT PREGNANCY IN INFLAMMATORY BOWEL DISEASE PATIENTS, FEASIBILITY AND RELIABILITY OF A NON-INVASIVE CROSS-SECTIONAL IMAGING MODALITY

2020 ◽  
Vol 158 (6) ◽  
pp. S-689-S-690
Author(s):  
Floris de Voogd ◽  
Harshad Joshi ◽  
Elsa A. Van Wassenaer ◽  
Geert R. D'Haens ◽  
Krisztina B. Gecse
2015 ◽  
Vol 33 (Suppl. 1) ◽  
pp. 17-25 ◽  
Author(s):  
Torsten Kucharzik ◽  
F. Petersen ◽  
C. Maaser

Background: The diagnosis of inflammatory bowel disease (IBD) is based on a combination of endoscopic, clinical and biochemical investigations as well as cross-sectional imaging. The applications of cross-sectional imaging in IBD are manifold. Ultrasonography has emerged as an important imaging modality in the diagnosis of Crohn's disease (CD) as well as for monitoring disease progression and in the therapeutic response to CD and ulcerative colitis (UC). Key Messages: Ultrasonography is non-invasive, radiation free, cheap, easy to use and well tolerated and accepted by patients. Bowel ultrasonography can be used for the primary diagnosis of CD as it has a similar sensitivity and specificity like that of MRI and CT, particularly in the case of CD. Ultrasonography can also be used to monitor treatment response to therapy and to detect disease recurrence of CD as well as UC. In CD, ultrasonography can also be used to detect complications such as strictures as well as extramural complications, including abscesses and fistulas. Contrast-enhanced ultrasonography is a useful tool that might be helpful to detect certain indications in CD, in particular the differentiation between abscesses and inflammation. Conclusion: A variety of advantages of bowel ultrasonography over other imaging modalities suggest the more frequent use of this method to manage IBD patients in daily practice. Bowel ultrasonography should be a standard tool in IBD centers.


2014 ◽  
Vol 6 (1) ◽  
pp. 73-83 ◽  
Author(s):  
Athanasios Athanasakos ◽  
Argyro Mazioti ◽  
Nikolaos Economopoulos ◽  
Christina Kontopoulou ◽  
Georgios Stathis ◽  
...  

Author(s):  
Aurélie Grandmougin ◽  
Ferdinando D’Amico ◽  
Thomas Remen ◽  
Silvio Danese ◽  
Marjorie Bonneton ◽  
...  

2021 ◽  
Vol 13 ◽  
pp. 1759720X2199697
Author(s):  
Jobie Evans ◽  
Mark Sapsford ◽  
Scott McDonald ◽  
Kenneth Poole ◽  
Tim Raine ◽  
...  

Background: Patients with inflammatory bowel disease (IBD) have an excess burden of axial spondyloarthritis (axSpA), which, if left untreated, may significantly impact on clinical outcomes. We aimed to estimate the prevalence of axSpA, including previously undiagnosed cases, in IBD patients from studies involving cross-sectional imaging and identify the IBD features potentially associated with axSpA. Methods: PubMed, Embase and Cochrane databases were searched systematically between 1990 and 2018. Article reference lists and key conference abstract lists from 2012 to 2018 were also reviewed. All abstracts were reviewed by two authors to determine eligibility for inclusion. The study inclusion criteria were (a) adults aged 18 years or above, (b) a clinical diagnosis of IBD and (c) reporting identification of sacroiliitis using cross-sectional imaging. Results: A total of 20 observational studies were identified: 12 used CT, 6 used MR and 2 utilised both computed tomography (CT) and magnetic resonance (MR) imaging. Sample sizes ranged from 25 to 1247 (a total of 4096 patients); 31 studies were considered to have low selection bias, 13 included two or more radiology readers, and 3 included rheumatological assessments. The prevalence of sacroiliitis, the most commonly reported axSpA feature, ranged from 2.2% to 68.0% with a pooled prevalence of 21.0% [95% confidence interval (CI) 17–26%]. Associated IBD features include increasing IBD duration, increasing age, male sex, IBD location, inflammatory back pain and peripheral arthritis. No significant difference in the prevalence of sacroiliitis between Crohn’s disease and ulcerative colitis was identified. Study limitations include variability in the individual study sample sizes and patient demographics. Conclusion: This review highlights the need for larger, well-designed studies using more sensitive imaging modalities and multivariable modelling to better estimate the prevalence of axSpA in IBD. An improved knowledge of the IBD phenotype(s) associated with axSpA and use of cross-sectional imaging intended for IBD assessment to screen for axSpA may help clinicians identify those patients most at risk.


Sign in / Sign up

Export Citation Format

Share Document